DCLK1 and obesity disorder: In tumor biology, it is involved in the development of multiple malignant tumors as a pro-cancer factor [50]; in obesity models, DCLK1 promotes myocardial fibrosis by activating the RIP2/TAK1 pathway [51], suggesting that it may affect fat metabolism by regulating the inflammatory microenvironment.